Literature DB >> 29803834

Epithelial Splicing Regulatory Protein 1 Inhibits the Invasion and Metastasis of Lung Adenocarcinoma.

Lingmei Li1, Lisha Qi1, Tongyuan Qu1, Changxu Liu1, Lu Cao1, Qiujuan Huang1, Wangzhao Song1, Lingyi Yang1, Hui Qi2, Yalei Wang1, Bin Gao1, Yuhong Guo1, Baocun Sun1, Bin Meng1, Bin Zhang3, Wenfeng Cao4.   

Abstract

Despite the development of various treatments, metastasis remains a significant problem with lung adenocarcinoma (ADC). The role and mechanism of epithelial splicing regulatory protein 1 (ESRP1), an epithelial-specific RNA binding protein, on promoting the invasion and metastasis of lung ADC remain to be fully elucidated. Immunohistochemical analysis in 125 human lung ADC tissue samples demonstrated that ESRP1 overexpression was inversely related to the presence of metastases, tumor size, and clinical stage of lung ADC. Impaired ESRP1 expression was also found to stimulate the invasion capacity of lung ADC cells both in vitro and in vivo. Functionally, overexpression of the ZEB1 gene decreased ESRP1 expression, and knockdown of the ZEB1 gene caused increased ESRP1 expression. On the basis of a gene array analysis, the expression of ESRP1 was associated with the regulation of the extracellular matrix. The expression of CD44 and fibroblast growth factor receptor, representatives that interact with the extracellular matrix, was studied. The CD44 subtypes promoted lung ADC cell invasion by regulating matrix metalloproteinase 2 expression. In conclusion, ESRP1 inhibits the invasion and metastasis of lung ADC and plays a role in regulating proteins involved in epithelial-to-mesenchymal transition.
Copyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29803834     DOI: 10.1016/j.ajpath.2018.04.012

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

Review 1.  Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.

Authors:  Debanwita Roy Burman; Shalini Das; Rahul Bhattacharya; Chandrima Das
Journal:  Mol Biol Rep       Date:  2021-01-05       Impact factor: 2.316

Review 2.  Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression.

Authors:  Ying Liu; Yiwen Li; Chengcheng Du; Shouxiang Kuang; Xuehao Zhou; Jinyu Zhang; Xiang Ao
Journal:  J Mol Med (Berl)       Date:  2022-09-27       Impact factor: 5.606

3.  Predicting prognosis of endometrioid endometrial adenocarcinoma on the basis of gene expression and clinical features using Random Forest.

Authors:  Fufen Yin; Xingyang Shao; Lijun Zhao; Xiaoping Li; Jingyi Zhou; Yuan Cheng; Xiangjun He; Shu Lei; Jiangeng Li; Jianliu Wang
Journal:  Oncol Lett       Date:  2019-06-20       Impact factor: 2.967

4.  Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients.

Authors:  Hyung Ho Lee; Andy Jinseok Lee; Weon Seo Park; Jongkeun Lee; Jongkeun Park; Boram Park; Jae Young Joung; Kang Hyun Lee; Dongwan Hong; Sung Han Kim
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

5.  Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells.

Authors:  Katherine A Wood; Charlie F Rowlands; Huw B Thomas; Steven Woods; Julieta O'Flaherty; Sofia Douzgou; Susan J Kimber; William G Newman; Raymond T O'Keefe
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

6.  ESRP1 as a prognostic factor of non-small-cell lung cancer is related to the EMT transcription factor of Twist.

Authors:  Jieda Cui; Peng Ren; Yan Li; Yunfan Ma; Jingdi Wang; Chutong Lin; Liang Jing; Xuexia Tong; Shaohua Ma; Juan Chen
Journal:  Thorac Cancer       Date:  2021-08-02       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.